NASDAQ
Edesa Biotech, Inc. (EDSA) has a free cash flow growth of 1.74% as of Friday, May 29, 2026. This represents a 114.53% increase compared to its 12-month average of -11.97%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.